All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â![BAVENCIO 200MG/10ML INJECTION_1 BAVENCIO 200MG/10ML INJECTION_1](https://assets.mrmed.in/product-images/product-images-1644928242411-758543131-200211_1%20BAVENCIO%20200MG10ML%20INJECTION.jpg)
![BAVENCIO 200MG/10ML INJECTION_2 BAVENCIO 200MG/10ML INJECTION_2](https://assets.mrmed.in/product-images/product-images-1644928242412-178595733-200211_2%20BAVENCIO%20200MG10ML%20INJECTION.jpg)
![BAVENCIO 200MG/10ML INJECTION_1 BAVENCIO 200MG/10ML INJECTION_1](https://assets.mrmed.in/product-images/product-images-1644928242411-758543131-200211_1%20BAVENCIO%20200MG10ML%20INJECTION.jpg)
Bavencio 200mg Injection 10ml
Prescription Required
Salt Composition : Avelumab
Manufacturer : MERCK LTD
Origin of Medicine : Germany
1 Vial(s) Of 10ml
PAP Information : Â Â Buy 1, Get 2 Free. Contact us for latest updates.
Program Overview: MERCK LTD Patient Assistance Program (PAP) is dedicated to helping patients in need of Bavencio 200 mg Injection 10ml the program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Purchase one vial of Bavencio 200 mg Injection 10ml and you will receive two free additional vials. Therefore, if eligible, you will have to pay only Rs. 1,21,705Â for three vials, which is Rs. 40,569 per vial.
With MrMed's MRP discount of Rs.25,095 per vial and Merck’s PAP program, the overall savings is around Rs.3 lakhs 19 thousand rupees.
Contact us for the latest updates on this exclusive offer.
Eligibility Criteria: To qualify for the Bavencio Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Avelumab 200 mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Merck’s can avail of it without having to purchase the medication from MrMed.
Patient Assistance Programs
Program Overview: MERCK LTD Patient Assistance Program (PAP) is dedicated to helping patients in need of Bavencio 200 mg Injection 10ml the program aims to provide eligible patients with access to the medication at a more affordable cost.
Program Benefits: Purchase one vial of Bavencio 200 mg Injection 10ml and you will receive two free additional vials. Therefore, if eligible, you will have to pay only Rs. 1,21,705Â for three vials, which is Rs. 40,569 per vial.
With MrMed's MRP discount of Rs.25,095 per vial and Merck’s PAP program, the overall savings is around Rs.3 lakhs 19 thousand rupees.
Contact us for the latest updates on this exclusive offer.
Eligibility Criteria: To qualify for the Bavencio Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Avelumab 200 mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.
Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].
Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Merck’s can avail of it without having to purchase the medication from MrMed.
Introduction to Bavencio 200mg Injection 10ml
Bavencio 200mg/10ml injection contains the active ingredient avelumab. It is an antineoplastic drug that belongs to the class of medications called PD-1/PD-L1 (programmed death ligand-1) inhibitors. It is used to treat Merkel cell carcinoma, a rare type of skin cancer that has spread to other body parts in adults and children 12 years and older. It is also indicated to treat urothelial carcinoma, cancer that originates in the urinary tract that has spread to nearby tissues or other body parts of the body in people whose cancer worsened during or within 12 months after it was treated with other anticancer medications. Â
It is also used in combination with other anticancer medicines to treat renal cell carcinoma, a type of kidney cancer that has spread to other body parts. PD-L1 is found on the surface of certain cancer cells and helps protect them from the immune system. It works by slowing or stopping the growth and spread of the cancer cells. Do not take Bavencio 200mg/10ml injection if you are allergic to avelumab or any other ingredients of this medicine. Inform your physician if you have liver diseases, hepatitis B, HIV/AIDS, or other immune diseases before initiating the therapy.Â
This medicine is not recommended for children and adolescents below 18. If you suffer from any of the reactions like infusion-related reactions, inflammation of your lungs, liver, pancreas, watery stools, or diarrhea, inform your doctor immediately and seek medical attention. Bavencio 200mg/10ml injection should not be used in pregnant and breastfeeding women. Inform your physician if you are pregnant or breastfeeding. Use effective contraception throughout the therapy to avoid pregnancy. The common adverse reactions are tiredness, muscle pain, diarrhea, nausea, rash, decreased appetite, urinary tract infection, and swelling in the body parts.
Uses of Bavencio 200mg Injection 10ml
- Merkel cell carcinoma
- Urothelial carcinoma
- Renal cell carcinoma
Therapeutic Effects of Bavencio 200mg Injection 10ml
Bavencio 200mg/10ml injection is a monoclonal antibody (a type of protein) that attaches to a specific target in the body called PD-L1. It binds to PD-L1 and blocks this protective effect, allowing the immune system to attack the tumor cells. It also induces antibody-dependent cell-mediated cytotoxicity, ultimately leading to cancer cell death. Â
Interaction of Bavencio 200mg Injection 10ml with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products. Certain medications may interact with Bavencio 200mg/10ml injection and reduce its effectiveness by causing undesirable side effects.Â
More Information about Bavencio 200mg Injection 10ml
- Store in a refrigerator (2°C to 8°C).
- Do not freeze. Store in the original package to protect from light.
- keep the injection away from the reach of children and pets.
- If you have missed any dosing appointments, inform your doctor and schedule immediately.
How to consume Bavencio 200mg Injection 10ml
It will be given to you by a doctor or nurse in a hospital or clinic setting trained in cancer chemotherapy. It is given as an intravenous infusion drip (into your vein). This will take one hour. Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity, body weight, and other factors.Â
Safety Advices for Bavencio 200mg Injection 10ml
 Â
Pregnancy
 ÂBavencio 200mg/10ml injection is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 1 months after your last dose is necessary. Â
 Â
Breast Feeding
 ÂBreastfeeding is not recommended in patients taking Bavencio 200mg/10ml injection because the medicine passes into the breast milk in small amounts and may harm your baby.Â
 Â
Lungs
 ÂIt is unknown whether Bavencio 200mg/10ml injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
 Â
Liver
 ÂBavencio 200mg/10ml injection is safe to administer in patients with liver problems. Dose adjustments are not necessary. However, inform your physician if you have any liver diseases or problems before initiating the therapy.Â
 Â
Alcohol
 ÂIt is unknown whether consuming alcohol is safe during the treatment with Bavencio 200mg/10ml injection. Inform your doctor if you are a chronic drinker.Â
 Â
Driving
 ÂBavencio 200mg/10ml injection may make you feel tired, dizzy, or sleepy. It is unsafe to drive or operate heavy machinery after taking this medicine.Â
Side Effects of Bavencio 200mg Injection 10ml
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.Â
CommonÂ
- Increased blood pressure
- Swelling in the legs and feet
- Skin rash
- Abdominal pain
- Decrease in appetite
- Diarrhea
- Nausea
- Decreased RBC counts
- Muscle pain
- Cough, shortness of breath
- Difficulty in talking
- TirednessÂ
SeriousÂ
- Heart problems
- Severe skin reactions
- Thyroid problems
- Liver injury
- Visual impairment
- Infusion reactions
Word of Advice
Report symptoms of infection, anemia, or bleeding immediately to your doctor. Do not breastfeed during the treatment and for 1 month after the last dose. Inform your doctor if you have kidney disease, liver disease, heart disease, diabetes, lung or breathing problems, or stomach problems before initiating the therapy. Do not stop taking the injection without consulting the physician. Stopping your treatment may stop the effect of the medicine. Your doctor may ask you to do certain tests to check for the effectiveness of the therapy and to monitor any unwanted side effects.Â
FAQs
Q 1. How long should I have to take Bavencio 200mg/10ml injection?
Bavencio 200mg/10ml injection is given as a cycle therapy. Your doctor will decide the dose and duration of the therapy based on your disease severity and condition.
Q 2. Can I take vitamin supplements with Bavencio 200mg/10ml injection?
Certain medications may interact with the effectiveness of Bavencio 200mg/10ml injection including prescription, over-the-counter medicines, vitamin or nutritional supplements, and herbal products. Inform your physician about your medication history.
Q 3. Is Bavencio 200mg/10ml injection cardiotoxic?
Heart problems like cardiac arrest and congestive heart failure may occur in patients receiving this medicine for the long term. Inform your physician of any pre-existing heart disorders before initiating the treatment.
Q 4. What is Bavencio 200mg/10ml injection patient information leaflet?
The FDA has a patient information leaflet containing a summary of the essential scientific information needed for the safe and effective use of the drug. Read the information leaflet thoroughly before starting the therapy.
Q 5. What are the infusion reactions of Bavencio 200mg/10ml injection?
Signs of shortness of breath, wheezing, chills or shaking, rash, flushing, low blood pressure, dizziness, fatigue, nausea, fever, back pain, and abdominal pain are the infusion reactions that may cause due to the Bavencio 200mg/10ml injection administration. Inform your physician and seek medical attention immediately if you face these reactions after administering the injection.
Fact Box of Bavencio 200mg Injection 10ml
Molecule name: Avelumab | Therapeutic class: Antineoplastics |
Pharmacological class: PD-1, PD-L1 inhibitors | Indications: 1. Merkel cell carcinoma 2. Urothelial carcinoma 3. Renal cell carcinoma |
References
- Bavencio 20 mg/mL concentrate for solution for infusion - Summary of Product Characteristics (SmPC) - (emc). www.medicines.org.uk. Revised February 2022. Accessed May 4, 2023. http://www.medicines.org.uk/emc/product/8453/smpc
- BAVENCIO-Avelumab Injection.; Revised June 2020. Accessed May 4, 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761049s009lbl.pdf
- Douglas F. Lake and Adrienne D. Briggs, Immunopharmacology, Lange’s Basic & Clinical Pharmacology, 14th Edition, 2018, 977-1002.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.